These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6318657)
1. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection. Scully BE; Fu KP; Neu HC Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511 [TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Zhou HH; Chan YP; Arnold K; Sun M Antimicrob Agents Chemother; 1985 Feb; 27(2):192-6. PubMed ID: 3985603 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents. Patel IH; Weinfeld RE; Konikoff J; Parsonnet M Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931 [TBL] [Abstract][Full Text] [Related]
5. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054 [TBL] [Abstract][Full Text] [Related]
6. Absolute bioavailability of ceftriaxone after intramuscular administration to healthy volunteers. Delsignore R; Baroni CM; Crotti G; Mineo F; Butturini U; Ascalone V; Cisternino M Chemotherapy; 1983; 29(3):157-62. PubMed ID: 6307601 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime. Wise R; Andrews JM Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime. Regamey C Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394 [TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Patel IH; Sugihara JG; Weinfeld RE; Wong EG; Siemsen AW; Berman SJ Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080 [TBL] [Abstract][Full Text] [Related]
14. [Fundamental study on ceftriaxone]. Kawakita K; Ide T; Urabe M; Miyazaki H; Ono S; Yamasaki K; Morita I; Sato M; Kawazoe T Jpn J Antibiot; 1984 Jun; 37(6):1029-34. PubMed ID: 6092736 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid. Kalager T; Digranes A; Bergan T; Solberg CO J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020 [TBL] [Abstract][Full Text] [Related]
16. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study. Nakashima N; Suzuki K; Hashimoto H; Nishijima K J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456 [TBL] [Abstract][Full Text] [Related]